ProThera, Inc.   Report issue

For profit Phase 3
Founded: Reno NV United States (2001)
Status: Acquired by Klaire Labs (2013)

Organization Overview

First Clinical Trial
2006
NCT00577330
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2006

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 3 Trials (3)

boswellia serrata (1 trial)

celery seed (1 trial)

phellodendron extract (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Osteoarthritis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 3